Can Field Sobriety Tests Identify Cannabis-Impaired Drivers? A Randomized Trial ↗
Randomized trial finds standard field sobriety tests have limited effectiveness for detecting cannabis impairment, challenging current enforcement approaches.
Browse more cannabis research, findings, methods, and limitations.
Randomized trial finds standard field sobriety tests have limited effectiveness for detecting cannabis impairment, challenging current enforcement approaches.
Study examines how recreational cannabis markets affect traffic deaths, suicides, and opioid overdose fatalities across US states.
Detailed lab protocol for testing cannabinoid compound activity at the CB2 receptor using cyclic AMP assays, supporting drug discovery efforts.
Study reveals functional interaction between endocannabinoid and kisspeptin systems in male reproductive control, explaining potential fertility effects of cannabis.
Caregivers report CBD benefits beyond seizure control for Dravet and Lennox-Gastaut patients, including improved alertness, behavior, and quality of life.
Dual-hit model shows prenatal risk factors combined with adolescent cannabis exposure produce more comprehensive schizophrenia-like symptoms than either alone.
Pilot study reveals sex differences in endocannabinoid tone during CUD and abstinence, supporting sex-specific treatment development.
Comprehensive review covers 40 years of endocannabinoid signaling research in the brain, highlighting its profound influence on nervous system function.
Systematic review supports cannabinoids as effective and safe add-on therapy for treatment-resistant spasticity in multiple sclerosis patients.
CBD consistently suppressed immune responses across animal and cell studies, but zero clinical trials have tested whether this helps humans with inflammatory diseases.
FAAH gene variation interacts with childhood trauma and anxiety to shape frontolimbic brain pathways, positioning the endocannabinoid system as a mediator of trauma effects.
Review reveals exercise activates the endocannabinoid system, potentially explaining runners high and exercises mood, pain, and anti-inflammatory benefits.
Greater CUD symptom severity increases probability of primary care diagnosis and treatment, supporting routine cannabis screening integration.
Dopamine D2 receptor gene variants linked to harmful alcohol use in young adults, with behavioral and psychological factors mediating the relationship.
Pilot trial finds oral cannabinoids may reduce systemic inflammation and affect viral reservoirs in people with HIV on antiretroviral therapy.
Systematic review finds next-day cannabis effects are possible but inconsistent, varying by dose, use frequency, and cognitive domain assessed.
Study examines whether medical cannabis laws change opioid and pain medication prescribing patterns for chronic non-cancer pain.
Canadian national data shows cannabis-using gamblers have more severe gambling problems, higher substance use, and worse mental health than non-using gamblers.
After one month, 63% of new medical cannabis patients reported effective pain relief, plus reduced medication use, less anxiety, and better sleep — though finding the right product was a common struggle.
Young adults show variable awareness of higher-risk cannabis behaviors, with some risks underestimated, challenging harm reduction communication strategies.
Veterans report using medicinal cannabis to replace prescription and OTC medications for pain and mental health, highlighting need for VA system integration.
Review examines marijuana impacts during pregnancy, noting some effects emerge at birth while others only appear during long-term childhood follow-up.
Study analyzes medical cannabis billboard content in Oklahoma, finding variable regulatory compliance and messaging that could normalize cannabis use.
Mesolimbic CB1 receptors mediate stress-driven cocaine seeking in rats, identifying a specific endocannabinoid target for relapse prevention.
Study models links between violent behavior, self-concept, and teen substance use, finding physical activity provides protective benefits.
Criminal justice referrals to cannabis treatment declined for teens and young adults after recreational legalization, changing how youth enter treatment.
Cannabis legalization changes how youth perceive risk and relate to CUD treatment, requiring adapted public health responses.
Focus groups reveal pregnant individuals preferences for specific cannabis delivery methods, shaped by perceived safety and symptom needs.
Study identifies treatment factors predicting cannabis use after residential SUD treatment in veterans, informing intervention during residential stays.
Review examines cannabinoids for nausea, cryotherapy for neuropathy, and scalp cooling for hair loss as complementary strategies to improve chemotherapy quality of life.
Using the large ABCD study cohort, researchers identified characteristics associated with early-onset cannabis use before age 13, including individual, family, and environmental risk factors.
Longitudinal study finds prenatal cocaine exposure associated with substance use disorder at age 21, showing lasting developmental impact.
Microglial CB2 receptor expression regulates neuroinflammation, with therapeutic potential for immunotherapy complications and neurodegenerative conditions.
THC causes cell death markers, microglial changes, and astrocyte reactivity in rat cerebellum, showing neurotoxic and inflammatory effects.
COVID-19 pandemic altered patterns of mental health and substance use ER visits in Nevada, with complex increases and decreases across conditions.
Cohort study finds people who use drugs deliberately use cannabis to reduce harm from more dangerous substances when evidence-based services are limited.
MTA study data examines whether childhood ADHD stimulant treatment is associated with later substance use through adolescence and early adulthood.
Clinical review addresses the complex overlap of cannabis use with ADHD and other psychiatric disorders in adolescents, emphasizing comprehensive assessment needs.
Duplicate entry addressing cannabis use comorbidity with ADHD and other psychiatric disorders in adolescents.
Chestnut-hemp sourdough improves gluten-free bread texture, nutrition, and taste while keeping ingredient lists clean.
Healthy Start Study links both prenatal and postnatal cannabis exposure to cognitive and behavioral outcomes at age 5, highlighting risks beyond pregnancy.
Study characterizes how minor cannabinoids (THCV, CBC, CBN, delta-8-THC) distribute through blood and brain after oral consumption.
Case report documents early-onset frontotemporal dementia after chronic cannabis abuse, raising questions about cannabis-neurodegeneration links.
Double-blind trial tests THC with CBD for Tourette syndrome, building on preliminary evidence that cannabinoids may reduce tics.
Review shows prenatal cannabis exposure linked to mental health problems from childhood through adulthood, mediated by endocannabinoid system disruption.
Study compares extraction solvents for hemp flower bioactive compounds, finding solvent choice affects both yield and antimicrobial activity.
Meta-analysis finds mixed evidence on cannabis and type 2 diabetes risk, with complex metabolic interactions through glucose and insulin pathways.
Medicinal chemistry study discovers new CB2-selective compounds through systematic scaffold modification, advancing cannabinoid drug development.
CANNA-TICS phase III trial provides the most rigorous evidence yet for nabiximols (Sativex) treatment of chronic tic disorders including Tourette syndrome.
Review highlights disconnect between public belief that cannabis is safe during pregnancy and scientific evidence of developmental impacts.